Home
Conditions
Hypercholesterolemia, Familial

Clinical trial condition

Hypercholesterolemia, Familial

Explore clinical trials studying Hypercholesterolemia, Familial. Study availability and eligibility vary by location and protocol.

23 public trials 4 recruiting studies

Refine in advanced search Browse all conditions

Hypercholesterolemia, Familial trial results

Recruiting

A Real-World Study of Long-Term Adherence and Persistence to Inclisiran, Evolocumab, and Alirocumab

NCT07543731

Conditions: Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +15 more
Locations: Novartis Basel, Switzerland

View Trial Details

Recruiting

Screening for Familial Hypercholesterolemia in Children

NCT06555120

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +10 more
Locations: CHRU Amiens Amiens, France

View Trial Details

Recruiting

Clinical Decision Support for Familial Hypercholesterolemia

NCT03989167

Conditions: Clinical Decision Support, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, +10 more
Locations: Universitetssjukhuset i Linköping Linköping, Sweden

View Trial Details

Recruiting

PET Imaging of Inflammation and Lipid Lowering Study

NCT04073797

Conditions: Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +22 more
Locations: University of Cambridge Cambridge, United Kingdom

View Trial Details

Completed

Prospective German Very High Cardiovascular Risk Patients Dyslipidemia Treatment Indication Registry

NCT03110432

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Dyslipoproteinemias, +14 more
Locations: Klinik und Poliklinik für Kardiologie, Universitätsklinikum Leipzig, Germany

Innere Medizin IV - Diabetologie, Endokrinologie und Nephrologie am Universitaetsklinikum Tübingen, Germany

Nephrologisches Zentrum Villingen-Schwenningen, Germany

View Trial Details

Completed

Expression of Pro- and Anti-inflammatory Cytokines During Anti-PCSK9 in Familial Hypercholesterolemia

NCT06231459

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
Locations: National Medical Center "20 de Noviembre", ISSSTE Mexico City, Mexico

View Trial Details

Completed

Evaluating the Efficacy of Pediatric Lipid Screening Alerts

NCT04118348

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +12 more
Locations: Geisinger Health System Danville, Pennsylvania, United States

View Trial Details

Completed

Reduction of Low-Density Lipoprotein Cholesterol (LDL-C) With PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder Study

NCT01375751

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +10 more
Locations: Not specified

View Trial Details

Completed

Comparison of the Plasma Lipoprotein Apheresis Systems DIAMED and MONET vs. the Whole Blood Apheresis System DALI

NCT03795038

Conditions: Cardiovascular Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, +10 more
Locations: Nephrocare Rostock GmbH Rostock, Mecklenburg-Vorpommern, Germany

Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden Dresden, Saxony, Germany

View Trial Details

Completed

Regeneron 1331 Kinetics Sub-Study HoFH

NCT04722068

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +10 more
Locations: University of Pennsylvania Philadelphia, Pennsylvania, United States

Department of Vascular Medicine Amsterdam UMC Amsterdam, AZ, Netherlands

View Trial Details

Hypercholesterolemia, Familial

Hypercholesterolemia, Familial trial results

Related conditions